特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 随着政府采购领域整治串通投标（陪标）行为的广泛开展，通过串通投标（陪标）行为谋取高 价中标的现象得到了抑制。随之而来的，由于竞争加剧，恶意低价中标（成交）现象又浮出水 面，一些供应商抱着先低价中标（成交），然后再通过偷工减料、降低标准或高价履约等方式 获利的心态，恶意压低投标报价进行竞争，不仅扰乱了正常的政府采购秩序，更给采购人履职 和提供公共服务增加了难度。因此，如何有效遏制恶意低价竞争行为，成为采购人和各级政府 采购监管部门必须面对和解决的问题。财政部印发的《关于推动解决政府采购异常低价问题的 通知》（财库〔2 0 2 6〕2号，以下简称《通知》），为采购人和监管部门共同遏制恶意低价竞 争行为提供了"良药"。 《通知》从三个层面对如何解决异常低价问题提出了要求，即科学确定采购需求、精准识别异 常低价、严把合同履约关口。 加强政府采购需求管理 政府采购需求管理是政府采购活动的源头和基础。制定科学合理的采购需求，不仅能保证项目 实施有的放矢，更是防范异常低价的前提和根本。异常低价之所以会出现 ...

Core Viewpoint - The article discusses the implementation of the Ministry of Finance's notification aimed at addressing the issue of abnormally low prices in government procurement, promoting a healthy market order characterized by quality and fair pricing [2]. Group 1: Government Procurement Overview - In 2024, the total amount of government procurement in China is expected to exceed 3.3 trillion yuan, accounting for over 12% of national fiscal expenditure, covering various sectors including goods, services, and engineering [2]. - Abnormally low prices in government procurement are identified as a significant issue, particularly the extreme cases of "1 yuan bidding" or even "0 yuan bidding," which, while seemingly absurd, occur more frequently than expected [2][3]. Group 2: Causes and Implications of Low Bidding - The phenomenon of zero-price bidding is linked to a long-term strategy where companies prioritize future revenue over immediate costs, similar to the business model in the printer industry where low-priced machines are sold alongside high-priced consumables [3]. - The article highlights that the low bidding behavior is a form of "involution" that depletes both corporate development potential and fiscal efficiency, ultimately harming public interests [3]. Group 3: Regulatory Measures - The notification emphasizes the need for improved management of procurement projects, particularly in sectors with high usage of consumables, such as printing and medical equipment, to prevent suppliers from charging additional fees outside of contractual agreements [3]. - To combat the issue of abnormally low bidding, there is a call for the enhancement of the legal framework governing government procurement, including the revision of laws to clearly define standards and responsibilities related to low pricing [7][5]. Group 4: Responsibilities and Accountability - The notification establishes four warning mechanisms for detecting abnormally low bids, allowing evaluation committees to request explanations from bidders, with non-compliance leading to invalid bids [8]. - It is crucial to clarify responsibilities among all parties involved in procurement to ensure accountability, with consequences for non-compliance, thereby fostering a sustainable procurement ecosystem [8].

Core Viewpoint - The issuance of the "Notice on Promoting the Resolution of Abnormal Low Bidding in Government Procurement" aims to address the chaotic and harmful competition characterized by abnormal low bidding, promoting a market order of quality and reasonable pricing [1][5] Group 1: Government Procurement Market Overview - In 2024, the total amount of government procurement in China is expected to exceed 3.3 trillion yuan, accounting for over 12% of national fiscal expenditure, covering various sectors including goods, services, and engineering [1] - Abnormal low bidding has become a significant issue in government procurement, with extreme cases such as "1 yuan bidding" and even "0 yuan bidding" being more common than expected [1][2] Group 2: Long-term Profit Models - Some companies engage in "0 yuan bidding" with the expectation of generating continuous revenue from subsequent services, similar to the model used in the printer industry where low-priced machines are sold alongside high-priced consumables [2] Group 3: Regulatory Framework and Responsibilities - To prevent abnormal low bidding, there is a need to improve the legal framework, including amendments to the Government Procurement Law and related regulations to clearly define standards and responsibilities [3][4] - The "Notice" establishes four warning mechanisms for detecting abnormal low bidding, allowing evaluation committees to request explanations for significantly low bids, which can be deemed invalid if not satisfactorily justified [4] Group 4: Conclusion and Future Directions - The essence of abnormal low bidding is internal consumption and unsustainable competition, necessitating strengthened regulations and clearer responsibilities to create a healthy and sustainable government procurement ecosystem [5]

"1元中标""0元中标"，这种异常低价的乱象在政府采购市场屡见不鲜。日前，财政部印发《关于推 动解决政府采购异常低价问题的通知》，整治政府采购领域"内卷式"竞争，促进形成优质优价、良性竞 争的市场秩序。 政府采购市场是国内市场的重要组成部分。统计显示，2024年全国政府采购总额突破3.3万亿元， 占全国财政支出的比重超12%，覆盖货物、服务、工程等全领域。推进全国统一大市场建设，必须消除 政府采购中的各类不合理限制和壁垒，整治异常低价问题，营造公平竞争的市场环境。 政府采购的采购人在选择中标方时，可根据采购需求和项目特点，选择最低评标价法或者综合评分 法。最低评标价法主要适用于技术、服务标准明确、统一的通用类项目，只围绕价格开展竞争，既能保 障基本功能和质量，也能节约成本。对于技术复杂、性质特殊的大型装备、专业化服务等项目，则可以 采用综合评分法，围绕产品性价比进行评审，实现优质优价采购。这两种评审方法，价格都是重要因 素，影响着谁能在投标中胜出。 实践中，异常低价的身影经常出现，比如，有的地方全自动生化免疫流水线以1元中标、有的地方 职业技能培训项目以0元中标，令公众咋舌。供应商以远低于成本的价格投标，实现 ...

从动机上看，供应商压低价格进行投标，无非就是为了在激烈的招投标中获胜。而不计成本以异常低价 进行投标，目的往往在于挤掉竞争对手、扩大市场份额。在以异常低价中标后，项目履约则面临着巨大 风险，产品、服务的质量难以保障，"低价冲标、低质履约"，供应商还可能会通过捆绑销售、追加费用 等方式进行"找补"，变相抬高实际交易价格。 可见，这种"最低价中标"并非正常的市场竞争，而是恶性竞争、"内卷式"竞争，扰乱了公平有序的市场 环境。同时，严重影响财政资金效益，最终损害公共利益。 "1元中标""0元中标"，这种异常低价的乱象在政府采购市场屡见不鲜。日前，财政部印发《关于推动解 决政府采购异常低价问题的通知》，整治政府采购领域"内卷式"竞争，促进形成优质优价、良性竞争的 市场秩序。 政府采购市场是国内市场的重要组成部分。统计显示，2024年全国政府采购总额突破3.3万亿元，占全 国财政支出的比重超12%，覆盖货物、服务、工程等全领域。推进全国统一大市场建设，必须消除政府 采购中的各类不合理限制和壁垒，整治异常低价问题，营造公平竞争的市场环境。 政府采购的采购人在选择中标方时，可根据采购需求和项目特点，选择最低评标价法或者综合 ...

政府采购市场是国内市场的重要组成部分。推进全国统一大市场建设，必须消除政府采购中的各类不合 理限制和壁垒，整治异常低价问题，营造公平竞争的市场环境。 "1元中标""0元中标"，这种异常低价的乱象在政府采购市场屡见不鲜。日前，财政部印发《关于推动解 决政府采购异常低价问题的通知》，整治政府采购领域"内卷式"竞争，促进形成优质优价、良性竞争的 市场秩序。 政府采购市场是国内市场的重要组成部分。统计显示，2024年全国政府采购总额突破3.3万亿元，占全 国财政支出的比重超12%，覆盖货物、服务、工程等全领域。推进全国统一大市场建设，必须消除政府 采购中的各类不合理限制和壁垒，整治异常低价问题，营造公平竞争的市场环境。 在过程管控方面，实施政府采购异常低价审查。以往对"异常低价"难以认定，此次文件明确了量化标 准，规定了启动异常低价投标审查程序的具体情形，提升了可操作性。 在事后监管方面，强化履约验收。政府采购不能"一购了之"，必须跟踪履约情况、落实履约责任。履约 验收不能"走过场"，而是要细致落实每一项技术和商务要求是否履行到位。如供应商不履行合同或者未 按合同约定履行合同导致验收不合格的，采购人应当依法追究其违约 ...

Core Viewpoint - The article discusses the rampant issue of low-price procurement in the medical equipment sector, highlighting a recent case where a medical device was awarded a contract for only 0.01 yuan, raising concerns about the integrity of the procurement process and the underlying causes of such anomalies [2][7][11]. Group 1: Procurement Anomalies - A recent procurement case for an automatic biochemical immunoassay line resulted in a winning bid of only 0.01 yuan, despite previous attempts to award the contract being canceled due to irregularities [4][7]. - Another case involved a project with a budget of 3 million yuan, which was awarded for just 1,000 yuan, prompting investigations into the procurement process [9][11]. - The article notes that the normal market price for such medical equipment typically ranges from 500,000 to 2 million yuan, indicating significant discrepancies in the awarded prices [11]. Group 2: Government Response - The Ministry of Finance has proposed measures to address the issue of abnormally low bids, including strengthening procurement demand management, enhancing low-price review mechanisms, and enforcing strict compliance and accountability [12][20]. - The article emphasizes the need for improved legal frameworks and regulatory oversight to prevent such procurement irregularities from continuing [15][20]. Group 3: Underlying Causes - The article identifies that the low-price procurement phenomenon is often a reflection of a commercial bribery chain, where suppliers offer equipment at extremely low prices in exchange for exclusive contracts for consumables [13][14]. - It also highlights the role of outdated regulations and ineffective enforcement mechanisms that fail to address the root causes of these procurement issues [15][17]. - Internal governance issues within medical institutions, such as concentrated decision-making power and inadequate oversight, contribute to the prevalence of these procurement anomalies [18][19]. Group 4: Recommendations for Improvement - The article suggests that long-term solutions should include enhancing legal regulations, improving comprehensive oversight, and reforming internal systems within hospitals to mitigate risks associated with procurement [20][21].

Core Viewpoint - The Ministry of Finance has issued a notice to address the issue of abnormally low bids in government procurement, signaling a shift from a focus on low prices to quality and effectiveness in the medical equipment market [1][3]. Government Procurement Reform - The new draft aims to create a systematic governance framework to tackle the persistent issue of low-price bidding in government procurement, particularly in the medical sector [3][5]. - Pilot programs have been initiated in various free trade zones and cities to address the problem of abnormal low-price bids [3]. Abnormal Low-Price Bidding Issues - The medical equipment sector has seen extreme price reductions, with bids often significantly below market rates, raising concerns about quality and safety [4][5]. - Examples include a bid of 1,000 yuan for a 3 million yuan project, highlighting the risks associated with such low bids [4]. Impact on Industry Competition - Abnormal low-price bidding has led to a decline in the quality of medical equipment and services, affecting patient safety and healthcare outcomes [5]. - The competition has forced some manufacturers to shift focus from R&D to lower-end products, hindering the advancement of domestic brands [5]. New Procurement Guidelines - The draft emphasizes a full lifecycle cost approach, requiring that ongoing maintenance and consumable costs be considered in bid evaluations [6]. - It introduces a two-stage evaluation process for complex equipment, ensuring that quality is prioritized over price [6]. Monitoring and Accountability - The draft outlines clear criteria for identifying abnormal low-price bids, aiming to prevent extreme cases from occurring [7]. - Suppliers will be required to provide cost breakdowns, and the evaluation committee will verify prices against market standards [7]. Market Restructuring - The new regulations are expected to shift market dynamics, concentrating resources on high-quality companies and altering the competitive landscape between domestic and foreign brands [8][9]. - Domestic companies must transition from competing on price to emphasizing value, or risk losing market share [9]. Opportunities for Foreign Brands - Foreign brands may benefit from the new focus on quality and lifecycle costs, allowing them to leverage their technological advantages in the market [10][11]. - The policy changes will require foreign companies to adapt their pricing strategies and enhance local services to maximize their market potential [11]. Innovation and Development - The new policies are anticipated to foster innovation within the industry, encouraging companies to invest in R&D and focus on developing innovative medical devices [11]. - With a significant budget for medical equipment updates, the new regulations will direct funds towards high-quality products and services, promoting a transition to high-quality development in the industry [11].